Characterization of antimitochondrial antibodies in healthy adults
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
The detection of antimitochondrial antibodies (AMAs) is an important criterion for the diagnosis of primary biliary cirrhosis (PBC). During the last decade, the mitochondrial autoantigens have been cloned, sequenced, and identified as members of the 2-oxo-acid dehydrogenase pathway, including the E2 subunits of pyruvate dehydrogenase (PDC-E2), branched-chain 2-oxo-acid dehydrogenase (BCOADC-E2), and 2-oxo-glutarate dehydrogenase (OGDC-E2). We have developed a rapid and sensitive diagnostic test for use in PBC based on a triple hybrid recombinant molecule (r-MIT3) that contains the autoepitopes of PDC-E2, BCOADC-E2, and OGDC-E2. To help understand the frequency and antigen specificity of AMAs in an asymptomatic population and to identify patients with early disease, we investigated the prevalence of AMA, by enzyme-linked immunosorbent assay (ELISA), in a cohort of 1,530 people from northern Italy. Positive sera were further analyzed for immunoglobulin (Ig) isotypes, subclasses, and epitopes of AMA by a combination of ELISA and immunoblotting. In this cohort of 1,530 people, 9 (0.5%) reacted to r-MIT3 by ELISA. Of the 9 reactive sera, 2 recognized PDC-E2, 2 of 9 recognized BCOADC-E2, 1 of 9 recognized OGDC-E2, 2 of 9 recognized both PDC-E2 and BCOADC-E2, and 1 of 9 recognized PDC-E2 and OGDC-E2. AMA reactivity was primarily IgM and IgA. Epitope mapping revealed an AMA pattern of reactivity to PDC-E2 that differed from that found in patients with histologically proven PBC in most of the sera. However, 1 sera of a 72-year-old female with a normal alkaline phosphatase had an AMA profile identical to typical PBC. After a variable follow-up period (8-14 months), sera from 8 of 9 of these people were re-obtained for AMA and relative epitope mapping. Interestingly, the reactivity had a wider AMA pattern than before.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“AMA testing is not specific for PBC, and should always be targeted: the population frequency of AMA positivity is high (up to 1/1000) whereas PBC prevalence is lower (up to 0.4/1000) [42,43].”
From EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. (2017) · cites this paper as [42]
In the citing paper
“More recent large-scale blood donor and population studies have suggested that low titre AMA positivity in the context of normal LFTs is seen in ~0.5% of the population.85 86”
From The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines (2018) · cites this paper as [85]
Citations
Cites
Kaplan, M. M. (1987) · New England Journal of Medicine · doi:10.1056/nejm198702263160907 · Cited by 1,959
Dominance and Crypticity of T Cell Antigenic Determinants
Sercarz, E. (1993) · Annual Review of Immunology · doi:10.1146/annurev.immunol.11.1.729 · Cited by 855
Kaplan, M. M. (1996) · New England Journal of Medicine · doi:10.1056/nejm199611213352107 · Cited by 455
Natural history of early primary biliary cirrhosis
Metcalf, J. V., Mitchison, H. C., Palmer, J. M., Jones, D. E., Bassendine, M. F., & James, O. F. (1996) · The Lancet · doi:10.1016/s0140-6736(96)04410-8 · Cited by 421
Use of designer recombinant mitochondrial antigens in the diagnosis of primary biliary cirrhosis
Leung, P. S. C., Iwayama, T., Prindiville, T., Chuang, D. T., Ansari, A. A., Wynn, M. R., Dickson, R., Coppel, R., & Gershwin, E. M. (1992) · Hepatology · doi:10.1002/hep.1840150302 · Cited by 350
Self-citationMitchison, H. C., Bassendine, M. F., Hendrick, A., Bennett, M. K., Bird, G., Watson, A. J., & James, O. F. W. (1986) · Hepatology · doi:10.1002/hep.1840060609 · Cited by 230
Price, B. E., Rauch, J., Shia, M. A., Walsh, M. T., Lieberthal, W., Gilligan, H. M., O'Laughlin, T., Koh, J. S., & Levine, J. S. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.5.2201 · Cited by 206
Van de Water, J., Cooper, A., Surh, C. D., Coppel, R., Danner, D., Ansari, A., Dickson, R., & Gershwin, M. E. (1989) · New England Journal of Medicine · doi:10.1056/nejm198905253202104 · Cited by 201
Self-citationSurh, C. D., Coppel, R., & Gershwin, M. E. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.9.3367 · Cited by 167
Self-citationPengo, V, Biasiolo, A., Brocco, T., Tonetto, S., & Ruffatti, A. (1996) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650355 · Cited by 159
Research works printed but not linked: 5
- Myszor, 1990, Q J Med, 75, 377
- Leung, 1995, Hepatology, 22, 505
- Tsuneyama, 1995, Hepatology, 21, 1031
- Shlomchik, 1986, J Exp Med, 161, 88
- Sercarz, 1993, Annu Rev Immunol, 11, 729, 10.1146/annurev.iy.11.040193.003501 · doi:10.1146/annurev.iy.11.040193.003501 · Paper page
Cited by
Items 101–146 of 146
Masuda, J.-I., Omagari, K., Miyakawa, H., Hazama, H., Ohba, K., Kinoshita, H., Matsuo, I., Isomoto, H., Murata, I., & Kohno, S. (2002) · Autoimmunity · doi:10.1080/08916930290016556 · Cited by 8
“Serial examination of immunofluorescence, immunoblotting, enzyme inhibition assay, and liver function tests including ALT and ALP was performed in the four patients with reactive sera against 50 and 52 kDa component of BHM by immunoblotting for 2–5 years to determine whether these patients subsequently develop PBC.”
BackgroundResultInfluentialSügimura, T., Shiokawa, S., Haraoka, S., Fujimoto, K., Ohshima, K., Nakamuta, M., & Nishimura, J. (2003) · Liver International · doi:10.1034/j.1478-3231.2003.00866.x · Cited by 8
“Anti-mitochondrial antibody (AMA) is present in the serum in excess of 95% of PBC patients, while it is very rarely found in non-PBC individuals (3, 4).”
BackgroundPrimary biliary cholangitis associated with warm autoimmune hemolytic anemia
González-Moreno, E. I., Martínez‐Cabriales, S. A., Cruz‐Moreno, M. A., Borjas-Almaguer, O. D., Cortéz-Hernández, C. A., Bosques‐Padilla, F., Garza, A. A., González, J. A., García‐Compeán, D., Ocampo‐Candiani, J., et al. (2016) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12303 · Cited by 7
Cholangiocytes and primary biliary cirrhosis: prediction and predication
Gershwin, M. E., & de Water, J. V. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13583 · Cited by 7
“Work with recombinant autoantigens has shown that the presence of AMAs is virtually diagnostic of PBC and that, while they may be detected in the sera of asymptomatic people years before the clinical diagnosis of PBC, they are very rarely found in non-PBC individuals (4, 5).”
BackgroundAutorinnen/Autoren, & Collaborators (2025) · Zeitschrift für Gastroenterologie · doi:10.1055/a-2558-5204 · Cited by 10
Ishibashi, H., Nakanuma, Y., Ueno, Y., Egawa, H., Koike, K., Komori, A., Sakisaka, S., Shimoda, S., Shirabe, K., Zeniya, M., et al. (2012) · Kanzo · doi:10.2957/kanzo.53.633 · Cited by 7
Ahmad, A., Dahle, C., Rönnelid, J., Sjöwall, C., & Kechagias, S. (2022) · Diagnostics · doi:10.3390/diagnostics12071572 · Cited by 7
“64%) that used ELISA and IIF on rat kidney sections, respectively [11,12].”
MethodResultAnti-mitochondrial autoantibodies—milestone or byway to primary biliary cholangitis?
Tanaka, A. (2017) · Annals of Translational Medicine · doi:10.21037/atm.2017.01.42 · Cited by 7
“individuals who are AMA seropositive subsequently develop PBC? It is known that AMA are occasionally detectable in healthy individuals (15,16), or patients with other autoimmune or non-autoimmune diseases (17,18).”
BackgroundOrlien, S. M. S., Ahmed, T. A., Ismael, N. Y., Berhe, N. B., Lauritzen, T., Gundersen, S. G., & Johannessen, A. (2018) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2018/4980597 · Cited by 5
The X-factor in primary biliary cirrhosis: monosomy X and xenobiotics
Bianchi, I., Lleò, A., Bernuzzi, F., Caliari, L., Smyk, D. S., & Invernizzi, P. (2012) · Autoimmunity Highlights · doi:10.1007/s13317-012-0043-2 · Cited by 5
Clark, V., & Levy, C. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-118-5_3 · Cited by 5
Tan, S. Y., Ayutyanont, N., Bhattarai, B., Movahedi, Z., Jayaram, L., Gish, R. G., & Nadir, A. (2017) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2017-000158 · Cited by 5
Washington, K., & Manns, M. P. (2017) · Elsevier eBooks · doi:10.1016/b978-0-7020-6697-9.00008-x · Cited by 4
Colchicine for primary biliary cirrhosis
Gong, Y., & Gluud, C. N. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004481 · Cited by 4
Trauner, M., & Boyer, J. L. (1999) · Current Opinion in Gastroenterology · doi:10.1097/00001574-199905000-00006 · Cited by 4
Methotrexate for primary biliary cirrhosis
Gong, Y., & Gluud, C. N. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004385 · Cited by 4
González, R. S., Washington, K., & Lohse, A. W. (2023) · Elsevier eBooks · doi:10.1016/b978-0-7020-8228-3.00008-9 · Cited by 3
Sebode, M., Bantel, H., Baumann, U., Bufler, P., Demir, M., Dold, L., Keitel, V., Klein, R., Kremer, A. E., Jansen, P. L., et al. (2026) · Zeitschrift für Gastroenterologie · doi:10.1055/a-2769-2475 · Cited by 2
Tanaka, A., Leung, P. S. C., Bowlus, C. L., & Gershwin, M. E. (2020) · Springer eBooks · doi:10.1007/978-3-030-51709-0_22 · Cited by 2
Self-citationTanaka, A., & Gershwin, M. E. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-812102-3.00058-0 · Cited by 2
Selmi, C. F., Mackay, I. R., & Gershwin, M. E. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-384929-8.00062-9 · Cited by 2
Sclair, S. N., & Levy, C. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-37591-7.00042-2 · Cited by 3
Manzo, C., Maślińska, M., Castagna, A., Hysa, E., Merante, A., Milchert, M., Gravina, T., Sargın, B., Natale, M., Ruberto, C., et al. (2021) · Medicina · doi:10.3390/medicina57040350 · Cited by 3
Les anticorps anti-mitochondries sont-ils toujours le signe d’une cirrhose biliaire primitive ?
Dahlqvist, G., & Corpechot, C. (2014) · La Presse Médicale · doi:10.1016/j.lpm.2014.07.015 · Cited by 2
“[8] Mattalia A, Quaranta S, Leung P, Bauducci M, Van de Water J, Calvo P”
BackgroundCyclosporin A for primary biliary cirrhosis
Gong, Y., Christensen, E., & Gluud, C. N. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005526 · Cited by 2
Primary biliary cholangitis, a rising health burden
Elnaggar, M., Elkhattib, I., Abomhya, A., & Boyer, J. L. (2024) · Exploration of Immunology · doi:10.37349/ei.2024.00165 · Cited by 1
Primary Biliary Cirrhosis: The Future
Hirschfield, G. M., & Heathcote, E. J. (2008) · Clinics in Liver Disease · doi:10.1016/j.cld.2008.02.002 · Cited by 1
Primary Biliary Cholangitis: Its Science and Practice
Wang, L., Bowlus, C. L., Wang, F., & Gershwin, M. E. (2017) · Springer eBooks · doi:10.1007/978-3-319-50168-0_8 · Cited by 2
Schregel, I., Steinmann, S., & Schramm, C. (2022) · Gastroenterologie up2date · doi:10.1055/a-1922-9264 · Cited by 1
Probing the Effects of Multisite Mutations in the Lipoic Acid Region of the BCOADC-E2 Protein
Wang, J., Yang, M., Wei, H., Miao, W., Li, S., & Gao, X. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252413677 · Cited by 1
Heathcote, E. J., & Milkiewicz, P. (2007) · Wiley eBooks · doi:10.1002/9780470691861.ch11a · Cited by 1
Orphan drugs in development for primary biliary cirrhosis: challenges and progress
Lindor, K. D., Ali, A. H., & Byrne, T. (2015) · Orphan Drugs Research and Reviews · doi:10.2147/odrr.s69477
Novel triple expression hybrid clone from human sources for the detection of M2 antibodies
JIANG, X. H., ZHONG, R. Q., Fan, L. Y., Yin, H. U., Li, W.-W., Cao, L., & Kong, X. T. (2002) · Chinese Journal of Digestive Diseases · doi:10.1046/j.1443-9573.2002.00080.x
Chemokine receptors as therapeutic targets in liver disease
Parker, R. (2015) · University of Birmingham Institutional Research Archive (University of Birmingham)
Caso clinico: una mujer de 65 años, con prurito y astenia
Fajardo, A. (2003) · Salus Journal of Health Sciences
Cirrosis Biliar Primaria en una mujer de 65 años con prurito y astenia. A propósito de un caso
Fajardo, A., Colombet, M., & Mejías, M. T. P. A. (2003)
Targets and investigative treatments for primary biliary cholangitis
Ali, A. H., Carey, E. J., & Lindor, K. D. (2016) · Expert Opinion on Orphan Drugs · doi:10.1080/21678707.2016.1227240
“AMA is rarely found in healthy individuals, with a reported prevalence of 0.5% (tested in 1530 healthy Italians) [12].”
InfluentialAutoimmune Liver Diseases: Primary Biliary Cholangitis
Ali, A. H., Carey, E. J., & Lindor, K. D. (2016) · Springer eBooks · doi:10.1007/978-3-319-30103-7_16
Carey, E. J., & Levy, C. (2018) · Clinics in Liver Disease · doi:10.1016/s1089-3261(18)30044-8 · Cited by 1
Autoantibodies in Primary Biliary Cirrhosis
Komori, A. (2014) · Springer eBooks · doi:10.1007/978-4-431-54789-1_17
“determined the prevalence of AMA in a northern Italian healthy population, with a pMIT3-ELISA [23].”
BackgroundIkami, Y., Izumi, D., Hasegawa, Y., Suzuki, N., Sakaguchi, Y., Hakamata, T., Otsuki, S., Yagihara, N., Iijima, K., Kashimura, T., et al. (2022) · International Heart Journal · doi:10.1536/ihj.22-075
Challenges for diagnosis and treatment of primary biliary cholangitis
Tanaka, A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-85389-7.00007-7
Khakoo, N. S., & Levy, C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23947-2.00039-4
The Diagnostic Pathway for Patients with Cholestatic Liver Disease
Martins, A., Motta, R. V., & Cançado, G. G. L. (2026) · Clinics in Liver Disease · doi:10.1016/j.cld.2026.04.002
Jin, Y., Wang, Y., Xu, A., Wang, M., & Pan, K. (2026) · Laboratory Medicine · doi:10.1093/labmed/lmag063
Gilio, D., Magno, S., Palladino, L., Papini, P., Paoli, M., Pelosini, C., Santini, F., & Ceccarini, G. (2026) · Obesity and Endocrinology · doi:10.1093/obendo/wjag011
Metadata
- Authors
- Mattalia, A., Quaranta, S., Leung, P. S. C., Bauducci, M., Van de Water, J., Calvo, P. L., Danielle, F., Rizzetto, M., Ansari, A., Coppel, R. L., Rosina, F., & Gershwin, E. M.
- Affiliations
- University of California, Davis (US)
- Fondazione Ricerca Molinette (IT)
- Emory University (US)
- Monash University (AU)
- ORCID
- Venue
- Hepatology
- Published
- 1998-03
- Volume
- 27
- Issue
- 3
- Pages
- 656-661
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2148935965
- Cited by
- 146
- References
- 30
- Citations by year
- 2026: 4 · 2025: 2 · 2024: 4 · 2023: 5 · 2022: 5 · 2021: 4 · 2020: 4 · 2019: 7 · 2018: 8 · 2017: 8 · 2016: 7 · 2015: 7 · 2014: 5 · 2013: 5 · 2012: 6
- FWCI
- 2.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 6393 d)
- Locations
- Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (DK 39588)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Health Sciences › Medicine › Dermatology › Autoimmune Bullous Skin Diseases
- Keywords
- antimitochondrial antibodies, primary biliary cirrhosis, mitochondrial autoantigens, PDC-E2, epitope mapping, early disease detection
- MeSH terms
- Adult, Aged, Autoantibodies, Female, Humans, Immunoglobulin G, Immunoglobulin Isotypes, Liver Cirrhosis, Biliary, Male, Middle Aged, Mitochondria, Recombinant Proteins, Epitope Mapping
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.